Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGF vs sodium hyaluronate for mild to moderate knee osteoarthritis
ChiCTR2600124071Phase 4Completed
- Sponsor
- Yancheng First People's Hospital
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes, Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in knee osteoarthritis (OA) comparing Sodium hyaluronate arm with Concentrated growth factor arm (2 arms). Primary endpoint: Western Ontario and McMaster Universities Arthritis Index (WOMAC). Started May 2026; status: completed.
02
Drugs
sodium hyaluronateconcentrated growth factor
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2600124071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124071.